Pathogenic mechanisms in proliferative vitreoretinopathy

Archives of Ophthalmology

Volumn 115, Issue 2, 1997, Pages 237-241

  Campochiaro, Peter A ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RETINOIC ACID; STEROID;

BLOOD RETINA BARRIER; CHEMOTAXIS; CLINICAL TRIAL; EPIRETINAL MEMBRANE; HUMAN; MITOGENICITY; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; RETINA CELL; RETINA DETACHMENT; RETINA TEAR; RETINOPEXY; REVIEW; RISK FACTOR; SCLERA BUCKLING PROCEDURE; VITRECTOMY; VITREORETINOPATHY;

EID: 0031056197     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100150239014     Document Type: Review

References (49)

1. Havener WH. Massive vitreous retraction. Ophthalmic Surg Lasers. 1973;4:22.
2. Machemer R, Laqua H. Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975;80:1-33.
3. Laqua H, Machemer R. Glial cell proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975;80:602-618.
4. Sugita G, Tano Y, Machemer R, Abrams 6, Claflin A, Fiorentino G. Intravitreal autotransplantation of fibroblasts. Am J Ophthalmol. 1980;89:121-130.
5. Machemer R, Laqua H. A logical approach to the treatment of massive periretinal proliferation. Ophthalmology. 1978:85:584-593.
6. Algvere P, Kock E. Experimental fibroplasia in the rabbit vitreous: retinal detachment induced by autologous fibroblasts. Graefes Arch Clin Exp Ophthalmol. 1976;199:215-222.
7. The Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983;90:121-125.
8. Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 1991;112:159-165.
9. Girard P, Mimouan G, Karpouzas I, Montefiore G. Clinical risk for proliferative vitreoretinopathy after retinal detachment surgery. Retina. 1994;14:417-424.
10. Cowley M, Conway BP, Campochiaro PA, Kaiser D, Gaskin H. Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol. 1989:107:1147-1151.
11. Vinores SA, Campochiaro PA, Conway BP. Ultrastructural and electronimmunocytochemical characterization of cells in epiretinal membranes. Invest Ophthalmol Vis Sci. 1990:31:14-28.
12. Vinores SA, Campochiaro PA, McGehee R, Orman W, Hackett SF, Hjelmeland LM. Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia, and fibroblasts in vitreous culture. Invest Ophthalmol Vis Sci. 1990:31:2529-2545.
13. Mueller-Jensen K, Machemer R, Azarnia R. Autotransplantation of retinal pigment epithelium in intravitreal diffusion chamber. Am J Ophthalmol. 1975;80: 530-537.
14. Vinores SA, Derevjanik ML, Mahlow J, et al. Class III -lubulin in human retinal epithelial cells in culture and in epiretinal membranes. Exp Eye Ftes. 1995; 60:385-400.
15. Anderson DH, Stern WH, Fisher SK, Erickson PA, Borgula GA. The onset of pigment epithelial proliferation after retinal detachment. Invest Ophthalmol Vis Scl. 1981:21:10-16.
16. Heriot WJ, Machemer R. Pigment epithelial repair. Graefes Arch Clin Exp Ophthalmol. 1992:230:91-100.
17. Del Priore LV, Hornbeck R, Kaplan HJ, et al. Débridement of the pig retinal pigment epithelium in vivo. Arch Ophthalmol. 1995;113:939-944.
18. Campochiaro PA, Hackett SF, Vinores SA, Tobe T. The retinal pigmented epithelium and retinal wound repair. Great Basin Vis Sci Symp. 1996:2:2834.
19. Bryan JA III, Campochiaro PA. A retinal pigment epithelial cell-derived growth factor(s). Arch Ophthalmol. 1986:104:422-425.
20. Campochiaro PA, Hackett SF, Vinores SA. Growth factors in the retina and retinal pigmented epithelium. Prog Ret Eye Res. 1996:15:547-567.
21. Campochiaro PA, Hackett SF, Vinores SA, et al. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J Cell Sci. 1994:107:2459-2469.
22. Guerrin M, Moukadiri H, Chollet P, et al. Vasculotropin/vascular endothelial growth factor is an aulocrine growth factor for human retinal pigmented epithelial cells cultured in vitro.JCellPhysiol. 1995:64:385-394.
23. Kaiser D. Bacteria also vote. Science. 1996;272:1598-1599.
24. Fisher SK, Erickson PA, Lewis GP, Andersen DH. Intraretinal proliferation induced by retinal detachment. Invest Ophthalmol Vis Sci. 1991:32:1739-1748.
25. Lev/is GP, Matsumoto B, Fisher SK. Changes in the organization and expression of cytoskeletal proteins during retinal degeneration induced by retinal detachment. Invest Ophthalmol Vis Sci. 1995:36:2404-2416.
26. Cook B, Lewis GF, Fisher SK, Adler R. Apoptotic photoreceptor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Scl. 1995:36:990-996.
27. Campochiaro PA, Bryan JA III, Conway BP, Jaccoma EH. Intravitreal chemotactic and mitogenic activity: implication of blood-retinal barrier breakdown. Arch Ophthalmol. 1986:104:1685-1687.
28. Sen HA, Robertson TJ, Conway BP, Campochiaro PA. The role of breakdown of the blood-retinal barrier in cell-injection models of proliferative vitreoretinopathy. Arch Ophthalmol. 1988:106:1291-1294.
29. Jaccoma EH, Conway BP, Campochiaro PA. Cryotherapy causes extensive breakdown of the blood-retinal barrier: a comparison with argon laser photocoagulation. Arch Ophthalmol. 1985:103:1728-1730.
30. Brubaker RF, Pederson JE. Ciliochoroidal detachment. Surv Ophtha/mol. 1983; 27:281-289.
31. Campochiaro PA, Jerdan JA, Glaser BM. Serum contains chemoattractants for human retinal pigment epithelial cells. Arch Ophthalmol. 1984:102:1830-1833.
32. Leschey KH, Hackett SF, Singer JH, Campochiaro PA. Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1990:31:839-846.
33. Hui YN, Sorgente N, Ryan SJ. Posterior vitreous separation and retinal detachment induced by macrophages. GraefesArch Clin Exp Ophthalmol. 1987; 225:279-284.
34. Algvere P, Wallow IH, Martini B. The development of vitreous membranes and retinal detachment induced by intravitreal carbon microparticles. GraefesArch Clin Exp Ophthalmol. 1988:226:471-478.
35. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligandinduced apoptosis as a mechanism of immune privilege. Science. 1995;270: 1189-1192.
36. Campochiaro PA, Kaden IH, Vidaurri-Leal J, Glaser BM. Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells. Arch Ophthalmol. 1985:103:434-436.
37. Vinores SA, tenderer JD, Mahlow J, et al. Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells. Exp Eye Res. 1995;60:607-619.
38. Campochiaro PA, Glaser BM. Platelet-derived growth factor is chemotactic for retinal pigment epithelial cells. Arch Ophthalmol. 1985:103:576-579.
39. Harvey AK, Roberge F, Hjelmeland LM. Chemotaxis of rat retinal glia to growth factors found in repairing wounds. Invest Ophthalmol V/s Sci. 1987:28:1092-1099.
40. Chen, Y-S, Hackett SF, Schoenfeld C-L, et al. Localization of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Invest Ophthalmol Vis Sd. 1996;37:S120.
41. The Silicone Study Group. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial: Silicone Study report 2. Arch Ophthalmol. 1992;110:780-792.
42. Lewis H, Aaberg TM, Abrams GW. Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy. Am J Ophthalmol. 1991 ;111 : 8-14.
43. Rubsamen PE, Davis PA, Hernandez E, O'Grady GE, Cousin SW. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil. Arch Ophthalmol. 1994;112: 407-413.
44. Chandler DB, Rozakis G, de Juan E, Machemer R. The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy. Am J Ophthalmol. 1985:99:686-690.
45. Campochiaro PA, Hackett SF, Conway BP. Retinoic acid promotes densitydependent growth arrest in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1991:32:65-72.
46. Nakagawa M, Refojo MF, Marin JF, Doi M, Tolentino Fl. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1995:36:2388-2395.
47. Fekrat S, de Juan E, Campochiaro PA. The effect of oral 13-c/s-retinoic acid on retinal redetachments after surgical repair in eyes with proliferative vitreoretinopathy. Ophthalmology. 1995;102:412-418.
48. Sidle A, Palaty C, Dirks P, et al. Activity of the retinoblastoma family proteins, PRB, P107, and P130, during cellular proliferation and differentiation. Crit Rev Biochem MolBiol. 1996:31:237-271.
49. Sakamoto T, Kimura H, Scuric Z, et al. Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of a suicide gene: can proliferative vitreoretinopathy be a target of gene therapy? Ophthalmology. 1995; 102:1417-1424.